Syocin Biotech logo

Syocin Biotech

Syocin Biotech is a technology company.

Active
Website LinkedIn X
Updated: ·

About

Syocin Biotech develops high-precision protein-based biobactericides designed to combat bacterial phytopathogens affecting crop production and distribution. The company leverages a proprietary Synthetic Biology Platform to engineer and build these bactericidal proteins, enabling the rapid development of new, targeted solutions. These biobactericides are entirely biological, biodegradable, and non-toxic, functioning with high specificity to eliminate harmful bacteria while preserving the health of soil microbiomes.

The company was founded in 2019 in Rosario, Argentina, by Julia Roulet and Marcos Delas. Dr. Roulet brings expertise in Synthetic Biology and Microbiology, while Mr. Delas contributes a background in software engineering and business management. Their combined vision originated from the insight that synthetic biology could offer a sustainable and precise method to address plant bacterial diseases, ultimately improving global food availability.

Syocin's products serve agricultural stakeholders seeking effective and environmentally balanced methods for crop protection and disease treatment. The company’s long-term vision is to establish the capability for swift responses to any plant bacterial disease, including emergent or previously unknown pathogens, thereby enhancing food security through advanced biological interventions.

Financial History

Syocin Biotech has raised $50K across 1 funding round.

Total Raised
$50K
Valuation
N/A

Frequently Asked Questions

How much funding has Syocin Biotech raised?

Syocin Biotech has raised $50K in total across 1 funding round.